Your Article Summary
New users of metformin are at low risk of incident cancer: A cohort study among people with type 2 diabetes
Diabetes Care, 07/02/09
Evans JMM et al. - The results suggest that metformin use may be associated with a reduced risk of cancer. A randomized trial is needed to assess whether metformin is protective in a population at high risk for cancer.
Related Articles
Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09
Relevance Score: 84%
Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys
Journal of Diabetes and its Complications, 11/17/09
Relevance Score: 83%
Debating cancer and diabetes in Vienna
Practice Nursing, 11/10/09
Relevance Score: 83%
The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/09/09
Relevance Score: 83%
A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09
Relevance Score: 83%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Accuracy of Whole Blood Glucose Measurement When Venous Catheter Blood Samples Are Used on Glucose Meters
Diabetes Technology & Therapeutics, 12/16/09
Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/16/09
The relationship between primary health care organization and quality of diabetes care
The European Journal of General Practice, 12/16/09

See Latest Articles